|
1.Nakamura, H., et al. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem 269, 25143-25149 (1994). 2.Nakamura, H., et al. Partial purification and characterization of human hepatoma-derived growth factor. Clin Chim Acta 183, 273-284 (1989). 3.Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42, 3858-3863 (1982). 4.Izumoto, Y., Kuroda, T., Harada, H., Kishimoto, T. & Nakamura, H. Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus. Biochem Biophys Res Commun 238, 26-32 (1997). 5.Everett, A.D., Stoops, T. & McNamara, C.A. Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells. J Biol Chem 276, 37564-37568 (2001). 6.Kishima, Y., et al. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem 277, 10315-10322 (2002). 7.Abouzied, M.M., et al. Hepatoma-derived growth factor. Significance of amino acid residues 81-100 in cell surface interaction and proliferative activity. J Biol Chem 280, 10945-10954 (2005). 8.Sue, S.C., et al. PWWP module of human hepatoma-derived growth factor forms a domain-swapped dimer with much higher affinity for heparin. J Mol Biol 367, 456-472 (2007). 9.Yang, J. & Everett, A.D. Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein. J Mol Biol 386, 938-950 (2009). 10.Lukasik, S.M., et al. High resolution structure of the HDGF PWWP domain: a potential DNA binding domain. Protein Sci 15, 314-323 (2006). 11.Ge, Y.Z., et al. Chromatin targeting of de novo DNA methyltransferases by the PWWP domain. J Biol Chem 279, 25447-25454 (2004). 12.Yang, J. & Everett, A.D. Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain. BMC Mol Biol 8, 101 (2007). 13.Everett, A.D. Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart. Dev Dyn 222, 450-458 (2001). 14.Cilley, R.E., Zgleszewski, S.E. & Chinoy, M.R. Fetal lung development: airway pressure enhances the expression of developmental genes. J Pediatr Surg 35, 113-118; discussion 119 (2000). 15.Enomoto, H., et al. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology 36, 1519-1527 (2002). 16.Lepourcelet, M., et al. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development 132, 415-427 (2005). 17.Klagsbrun, M., Sasse, J., Sullivan, R. & Smith, J.A. Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the United States of America 83, 2448-2452 (1986). 18.Fausto, N. & Webber, E.M. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. Prog Liver Dis 11, 115-137 (1993). 19.Hu, T.H., et al. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer 98, 1444-1456 (2003). 20.Fausto, N. Growth factors in liver development, regeneration and carcinogenesis. Prog Growth Factor Res 3, 219-234 (1991). 21.Yoshida, K., et al. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol 13, 159-167 (2006). 22.Bernard, K., et al. Functional proteomic analysis of melanoma progression. Cancer Res 63, 6716-6725 (2003). 23.Zhang, J., et al. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Cancer Res 66, 18-23 (2006). 24.Uyama, H., et al. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 12, 6043-6048 (2006). 25.Yamamoto, S., et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 12, 117-122 (2006). 26.Hu, T.H., et al. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors. Dis Colon Rectum 52, 319-326 (2009). 27.Ooi, B., et al. Hepatoma-derived growth factor and its role in keloid pathogenesis. J Cell Mol Med (2009). 28.Yamamoto, S., et al. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Ann Surg Oncol 14, 2141-2149 (2007). 29.Chang, K.C., et al. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. International journal of cancer 121, 1059-1065 (2007). 30.Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374 (2003). 31.Narron, J.V., Stoops, T.D., Barringhaus, K., Matsumura, M. & Everett, A.D. Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr Res 59, 778-783 (2006). 32.Everett, A.D., Narron, J.V., Stoops, T., Nakamura, H. & Tucker, A. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol 286, L1194-1201 (2004). 33.Karihtala, P. & Soini, Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis 115, 81-103 (2007). 34.Culotta, V.C., Yang, M. & O''Halloran, T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 1763, 747-758 (2006). 35.Tsanou, E., et al. Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histol Histopathol 19, 807-813 (2004). 36.Sikka, S.C. & Hellstrom, W.J. Role of oxidative stress and antioxidants in Peyronie''s disease. Int J Impot Res 14, 353-360 (2002). 37.Carter, C.D., Kitchen, L.E., Au, W.C., Babic, C.M. & Basrai, M.A. Loss of SOD1 and LYS7 sensitizes Saccharomyces cerevisiae to hydroxyurea and DNA damage agents and downregulates MEC1 pathway effectors. Mol Cell Biol 25, 10273-10285 (2005). 38.Ushio-Fukai, M. & Alexander, R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264, 85-97 (2004). 39.Xia, C., et al. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67, 10823-10830 (2007). 40.Imrich, A., Ning, Y.Y. & Kobzik, L. Intracellular oxidant production and cytokine responses in lung macrophages: evaluation of fluorescent probes. J Leukoc Biol 65, 499-507 (1999). 41.Yoshida, K., et al. Expression of hepatoma-derived growth factor in hepatocarcinogenesis. J Gastroenterol Hepatol 18, 1293-1301 (2003). 42.Ren, H., et al. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol 22, 3230-3237 (2004). 43.Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K. & Donner, D.B. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 277, 5484-5489 (2002). 44.Lauffenburger, D.A. Cell motility. Making connections count. Nature 383, 390-391 (1996). 45.Curran, S. & Murray, G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36, 1621-1630 (2000). 46.Fridman, R., Toth, M., Pena, D. & Mobashery, S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55, 2548-2555 (1995). 47.Baldwin, A.S., Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107, 3-6 (2001). 48.Michalopoulos, G.K. Liver regeneration: molecular mechanisms of growth control. Faseb J 4, 176-187 (1990). 49.Selden, A.C. & Hodgson, H.J. Growth factors and the liver. Gut 32, 601-603 (1991). 50.Fausto, N. & Mead, J.E. Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest 60, 4-13 (1989). 51.Kristensen, D.B., et al. Proteome analysis of rat hepatic stellate cells. Hepatology 32, 268-277 (2000). 52.Mori, M., et al. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol 30, 459-469 (2004).
|